FROM ADJUVANT TO NEOADJUVANT CHEMOTHERAPY IN HIGH-RISK BREAST-CANCER - THE EXPERIENCE OF THE MILAN CANCER INSTITUTE - STEINER AWARD LECTURE 1992

被引:13
作者
BONADONNA, G
机构
[1] Division of Medical Oncology, Department of Medicine, Istituto Nazionale Tumori, Milan, 20133
关键词
D O I
10.1002/ijc.2910550102
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
[No abstract available]
引用
收藏
页码:1 / 4
页数:4
相关论文
共 20 条
[1]   PRIMARY CHEMOTHERAPY TO AVOID MASTECTOMY IN TUMORS WITH DIAMETERS OF 3 CENTIMETERS OR MORE [J].
BONADONNA, G ;
VERONESI, U ;
BRAMBILLA, C ;
FERRARI, L ;
LUINI, A ;
GRECO, M ;
BARTOLI, C ;
DEYOLDI, GC ;
ZUCALI, R ;
RILKE, F ;
ANDREOLA, S ;
SILVESTRINI, R ;
DIFRONZO, G ;
VALAGUSSA, P .
JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1990, 82 (19) :1539-1545
[2]   DRUGS 10 YEARS LATER - EPIRUBICIN [J].
BONADONNA, G ;
GIANNI, L ;
SANTORO, A ;
BONFANTE, V ;
BIDOLI, P ;
CASALI, P ;
DEMICHELI, R ;
VALAGUSSA, P .
ANNALS OF ONCOLOGY, 1993, 4 (05) :359-369
[4]  
BONADONNA G, 1992, CANCER RES, V52, P2127
[5]   COMBINATION CHEMOTHERAPY AS AN ADJUVANT TREATMENT IN OPERABLE BREAST-CANCER [J].
BONADONNA, G ;
BRUSAMOLINO, E ;
VALAGUSSA, P ;
ROSSI, A ;
BRUGNATELLI, L ;
BRAMBILLA, C ;
DELENA, M ;
TANCINI, G ;
BAJETTA, E ;
MUSUMECI, R ;
VERONESI, U .
NEW ENGLAND JOURNAL OF MEDICINE, 1976, 294 (08) :405-410
[6]   ADJUVANT CHEMOTHERAPY WITH DOXORUBICIN PLUS CYCLOPHOSPHAMIDE, METHOTREXATE, AND FLUOROURACIL IN THE TREATMENT OF RESECTABLE BREAST-CANCER WITH MORE THAN 3 POSITIVE AXILLARY NODES [J].
BUZZONI, R ;
BONADONNA, G ;
VALAGUSSA, P ;
ZAMBETTI, M .
JOURNAL OF CLINICAL ONCOLOGY, 1991, 9 (12) :2134-2140
[7]  
EBCTC Group, 1992, LANCET, V339, P1
[8]  
FISHER B, 1983, CANCER RES, V43, P1488
[9]   1-PHENYLALANINE MUSTARD (L-PAM) IN MANAGEMENT OF PRIMARY BREAST-CANCER - REPORT OF EARLY FINDINGS [J].
FISHER, B ;
CARBONE, P ;
ECONOMOU, SG ;
FRELICK, R ;
GLASS, A ;
LERNER, H ;
REDMOND, C ;
ZELEN, M ;
BAND, P ;
KATRYCH, DL ;
WOLMARK, N ;
FISHER, ER .
NEW ENGLAND JOURNAL OF MEDICINE, 1975, 292 (03) :117-122
[10]  
FISHER B, 1991, MED MANAGEMENT BREAS, P281